Grassi et al., 2004 - Google Patents

Detection of the M30 neoepitope as a new tool to quantify liver apoptosis: timing and patterns of positivity on frozen and paraffin-embedded sections

Grassi et al., 2004

View PDF
Document ID
2745304155626386416
Author
Grassi A
Susca M
Ferri S
Gabusi E
D’Errico A
Farina G
Maccariello S
Zauli D
Bianchi F
Ballardini G
Publication year
Publication venue
American journal of clinical pathology

External Links

Snippet

One of the first stages of apoptosis is cytokeratin cleavage mediated by caspases, which is associated with the expression of a neoepitope, the cleavage site of cytokeratin 18, identifiable by the M30 monoclonal antibody. The aim of this study was to evaluate the …
Continue reading at academic.oup.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis

Similar Documents

Publication Publication Date Title
Grassi et al. Detection of the M30 neoepitope as a new tool to quantify liver apoptosis: timing and patterns of positivity on frozen and paraffin-embedded sections
Nasr et al. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies
Jackson et al. Immunohistochemical techniques
KR101976219B1 (en) Biomarker for breast cancer
JP5619603B2 (en) Method for detecting hepatoma cells using anti-glypican 3 antibody
EP3254110B1 (en) Histochemical assay for evaluating expression of programmed death ligand 1 (pd-l1)
Endl et al. Antibodies against the Ki-67 protein: assessment of the growth fraction and tools for cell cycle analysis
Staack et al. Quantitation of apoptotic activity following castration in human prostatic tissue in vivo
JP5323261B2 (en) Use of bis-maleic anhydride cross-linking agent for fixation of cell or tissue samples
Slotnick et al. The Production of Congenital Malformations Using Tissue Antisera: V. Fluorescent Localization of Teratogenic Antisera in the Maternal and Fetal Tissue of the Rat
JP2021517242A (en) How to detect MAGEA4
Paueksakon et al. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining
KR102371964B1 (en) Methods for detecting markers of immune-related diseases
Orakpoghenor et al. A short review of immunochemistry
Kubo et al. The Fas system is not significantly involved in apoptosis in human hepatocellular carcinoma
Brzica et al. Role of microwave heating in antigen retrieval in cryosections of formalin-fixed tissues
Thomas et al. Nuclear terminal deoxynucleotidyl transferase in leukaemic infiltrates of testicular tissue
CN110531077B (en) Mesothelin immunohistochemical detection kit
Tanaka et al. Assessment of germ‐cell kinetics in the testes of patients with varicocele using image analysis of immunostained proliferating cell nuclear antigen
Tingstedt et al. Immunohistochemical detection of SWC3, CD2, CD3, CD4 and CD8 antigens in paraformaldehyde fixed and paraffin embedded porcine lymphoid tissue
Hayat Factors affecting antigen retrieval
Zamolo et al. Expression of p53 and apoptosis in discoid lupus erythematosus.
Kim Immunohistochemical study of the expression of α-smooth muscle actin and the proliferation marker Ki-67 of glomerulonephritis
CN111088242A (en) CTSS protein and use of gene encoding the same
Kacena et al. HistoChoice® as an alternative to formalin fixation of undecalcified bone specimens